Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > June Warrant volume today?
View:
Post by narmac on Jan 15, 2021 1:56pm

June Warrant volume today?

,,humm,,,,I see the volume is substantial today and its on the up side,,,which is a plus,,,,,,I am showing 28000 bought up so far today ,,up .0755 cents to .225,,,,,,,,,,intrresting at least!
Comment by narmac on Jan 15, 2021 2:47pm
,,,up to 46000 I see now,,,hummm,,the delta is at .500.
Comment by narmac on Jan 15, 2021 3:05pm
RVXCF is double the average volume today as well,,,41K,,,I am showing equal numbers for warrants and shares traded on the Candaian side at the moment,,,,,46K and 46K,,,,a tad odd,,but most likey a coincidence.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities